BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 603590 for the last quarter is 239.55 M CNY, and it's 17.62% higher compared to the previous quarter. The net income of Q3 24 is 33.77 M CNY.